Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database Analysis
-
Published:2024-06
Issue:
Volume:
Page:
-
ISSN:2152-2650
-
Container-title:Clinical Lymphoma Myeloma and Leukemia
-
language:en
-
Short-container-title:Clinical Lymphoma Myeloma and Leukemia
Author:
Tharakan SerenaORCID,
Feld JonathanORCID,
Van Hyfte GraceORCID,
Mascarenhas JohnORCID,
Tremblay Douglas
Reference17 articles.
1. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia;Elena;Blood,2016
2. Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories;Loghavi;Blood Adv,2018
3. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs;Rollison;Blood,2008
4. Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome;Patnaik;Am J Hematol,2015
5. How I diagnose and treat chronic myelomonocytic leukemia;Patnaik;Haematologica,2022